コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 eeze, persistent cough, shortness of breath, chest tightness).
2 oduction, shortness of breath, wheezing, and chest tightness.
3 minant symptoms were shortness of breath and chest tightness.
4 mptoms including breathlessness, wheeze, and chest tightness.
5 Symptoms included fever and chills (100%), chest tightness (93%), cough (80%), and shortness of bre
7 d blurred vision, and atypical symptoms like chest tightness and headache occurred in 86% and 66%, re
12 minal pain, diarrhoea, general pain, nausea, chest tightness, and tinnitus persisted throughout follo
13 al symptoms of dyspnea, cough, weakness, and chest tightness appear, usually within 1-3 days after ar
14 st, OA due to LMW agents was associated with chest tightness at work (2.22 [1.59-3.03]), daily sputum
15 four of the surveys) reported byssinosis or chest tightness at work had a significantly greater 15-y
16 een excessive loss of FEV(1) and byssinosis, chest tightness at work, and chronic bronchitis in cotto
17 spiratory symptoms, including byssinosis and chest tightness at work, is of value to predict the magn
20 led that the frequency of the experience of "chest tightness" decreased significantly across the phas
21 owed significant differences with respect to chest tightness during exercise, dyspnoea and gender.
22 piratory symptoms (cough, phlegm, wheeze, or chest tightness) during the previous 6 months were posit
24 nclude that in mild asthma, the sensation of chest tightness is distinct from the sensation of work a
25 .0; 95% CI = 1.4-2.86, P = .0001; wheeze and chest tightness: odds ratio = 2.34, 95% CI = 1.55-3.52,
27 any wheeze (OR, 1.52; 95% CI, 1.04, 2.21) or chest tightness (OR, 1.61; 95% CI, 1.04, 2.49), and days
28 f breath (OR, 2.33; 95% CI, 1.12, 5.06), and chest tightness (OR, 4.34; 95% CI, 1.76, 10.69), whereas
31 of receiving the second dose, she developed chest tightness, shortness of breath, tongue swelling, d
32 including increased "effort to breathe" and chest "tightness." We have tested the hypotheses that "e
34 symptoms (diffuse erythroderma, tachycardia, chest tightness, wheezing, facial swelling, dyspnea, hyp
35 COPD (cough, sputum, wheezing, dyspnoea, or chest tightness), with at least one of the symptoms last